🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Raquibul Hannan

ORCID: 0000-0003-1282-056X

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma

(2023)10.1158/1078-0432.c.6531062

Top 100%

0DataRank

Top 100%0 citations

Osama Mohamad, Alberto Diaz de Leon, Subrata Manna, Laurentiu M. Pop, Ze Zhang +22 more

Papers

Driven by 14 papers — median percentile 0. Top paper: “Adjuvant docetaxel for high-risk localized prostate cancer: Update of NRG Oncology/RTOG 0521.”.

Adjuvant docetaxel for high-risk localized prostate cancer: Update of NRG Oncology/RTOG 0521.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.333

N/A

1.0DataRank · unranked

11 citations

Theodore Karrison, Oliver Sartor, Leonard G. Gomella, Mahul B. Amin, James A. Purdy +15 more

Mapping cellular interactions from spatially resolved transcriptomics data

Nature Methods(2024)10.1038/s41592-024-02408-1

N/A

0.604DataRank · unranked

55 citations

Yunguan Wang, Woo Yong Chang, Alicia Malewska, Fabiana Napolitano, Jeffrey Gahan +20 more

SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation Trial

International Journal of Radiation Oncology*Biology*Physics(2021)10.1016/j.ijrobp.2021.10.137

N/A

0.494DataRank · unranked

26 citations

Samer Salamekh, Neil Desai, Aurélie Garant, Michael R. Folkert, Daniel N. Costa +15 more

A Multi-Institutional Phase 2 Trial of High-Dose SAbR for Prostate Cancer Using Rectal Spacer

International Journal of Radiation Oncology*Biology*Physics(2021)10.1016/j.ijrobp.2021.03.025

N/A

0DataRank · unranked

44 citations

Michael J. Zeléfsky, Raquibul Hannan, Neil Desai, Yair Lotan, Aaron Laine +9 more

Renal Lipid Metabolism Abnormalities in Obesity and Clear Cell Renal Cell Carcinoma

Metabolites(2021)10.3390/metabo11090608

N/A

0DataRank · unranked

33 citations

Laurentiu M. Pop, Chinnadurai Mani, Kala Turner, Christian Rivera, Sabiha Khatoon +4 more

Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2083

N/A

0DataRank · unranked

24 citations

Osama Mohamad, Alberto Diaz de Leon, Subrata Manna, Laurentiu M. Pop, Ze Zhang +22 more

Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer

European Urology(2023)10.1016/j.eururo.2023.02.016

N/A

0DataRank · unranked

60 citations

Mark F. McLaughlin, Laurentiu M. Pop, Iván Pedrosa, Payal Kapur, Aurélie Garant +13 more

Tumor loss-of-function mutations in STK11/LKB1 induce cachexia

JCI Insight(2023)10.1172/jci.insight.165419

N/A

0DataRank · unranked

20 citations

Aakash Y. Gandhi, Jorge Z. Granados, Tong Guo, Arun Gupta, Jinhai Yu +15 more

Mapping Cellular Interactions from Spatially Resolved Transcriptomics Data

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.18.558298

N/A

0DataRank · unranked

3 citations

Yunguan Wang, Woo Yong Chang, Alicia Malewska, Fabiana Napolitano, Jeffrey Gahan +20 more

Data from Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma

(2023)10.1158/1078-0432.c.6531062

Top 100%

0DataRank

Top 100%0 citations

Osama Mohamad, Alberto Diaz de Leon, Subrata Manna, Laurentiu M. Pop, Ze Zhang +22 more

Tumor neoantigenicity assessment with CSiN score incorporates clonality and immunogenicity to predict immunotherapy outcomes

Science Immunology(2020)10.1126/sciimmunol.aaz3199

N/A

0DataRank · unranked

50 citations

Shidan Wang, Lin Xu, Qinbo Zhou, Nirmish Singla, Jianjun Gao +9 more

A multimodal ensemble approach for clear cell renal cell carcinoma treatment outcome prediction

PubMed(2024)10.48550/arxiv.2412.07136

N/A

0DataRank · unranked

0 citations

Kai Wang, Payal Kapur, James Brugarolas, Raquibul Hannan, Jing Wang +1 more

Acute interstitial nephritis, a potential predictor of response to immune checkpoint inhibitors in renal cell carcinoma

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001198

N/A

0DataRank · unranked

31 citations

Roy Elias, Joseph Formella, William Schwartzman, Alana Christie, Qi Cai +9 more

Tumor Neoantigenicity Assessment with CSiN Score Incorporates Clonality and Immunogenicity to Predict Immunotherapy Outcomes

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.01.23.917625

N/A

0DataRank · unranked

5 citations

Shidan Wang, Lin Xu, Qinbo Zhou, Nirmish Singla, Jianjun Gao +8 more